Monday, July 26

vacuna

AstraZeneca, combinar, Corea del Sur, coronavirus, Covid 19, dosis, Noticias, Pfizer, Salud, vacuna, vacunacion

Study Shows Advantages of Combining Pfizer and AstraZeneca | Digital Trends Spanish

A study carried out in South Korea showed that a mixed COVID-19 vaccination of AstraZeneca and then an injection of Pfizer increased the levels of neutralizing antibodies by six times, compared to two doses of AstraZeneca. About 500 medical workers participated in the research. Of these, 100 received mixed doses, 200 received two doses of the Pfizer / BioNTech vaccine, and the remainder received two AstraZeneca vaccines. According to a Reuters articleAll showed neutralizing antibodies, which prevent the virus from entering cells and replicating, and the result of the mixed vaccine plan showed similar amounts of neutralizing antibodies found in the group that received two injections from Pfizer. A neutralizing activity was also detected against the main variants of greatest interest, ac...
coronavirus, Covid 19, efectos, Noruega, Noticias, Pfizer, Salud, vacuna, vacunacion, vacunas

Can vaccines increase breast size? | Digital Trends Spanish

The world had to accelerate research and the manufacture of vaccines to try to stop the coronavirus pandemic, therefore, it is possible that we still do not have knowledge of all the effects associated with drugs. Some of them may seem more unique than others, at least with respect to the comments of those affected themselves. Emma, ​​a young TikTok user, has pointed out on the platform that she thinks that the Pfizer vaccine may have increased the size of her breasts. The young woman assures that this would have started 15 days after having achieved the immunization of the vaccine. “It was kind of a crisis for me. I had to buy a bra one size larger, "he acknowledged. Although at some point it seemed almost anecdotal, the problem gained visibility when more women responded to the affec...
Covid 19, Noticias, Pfizer, Salud, vacuna, Variante Delta

Pfizer will update its vaccine to defeat Delta variant | Digital Trends Spanish

Concerns about Delta variant have made many laboratories that already have their vaccines approved against COVID-19, have decided to start studies to tailor efficacy against this contagious strain. One such company is Pfizer, which this July 8 announced that it is already in the process of updating. "Pfizer and BioNTech are conducting tests to confirm this expectation," according to a press release issued late Thursday. Both labs, which have worked together on the vaccine called BNT162b2, will make this update to directly address the Delta variant. For now they are producing material for a clinical trial, which they expect to begin in August, pending regulatory approvals from the FDA. Third dose of Pfizer But that is not all, since Pfizer and BioNTech are looking closely at the situat...
ensayos, gripe, gripe estacional, Moderna, Noticias, Salud, vacuna

Moderna begins trials of a flu vaccine | Digital Trends Spanish

Moderna has announced that its quadrivalent seasonal flu mRNA candidate vaccine has begun clinical trials. The pharmaceutical company reported that it administered its vaccine to the first group of volunteers in a clinical trial, marking the next stage of the company's work in these types of technologies after the success of its ani-COVID-19 vaccine. The efficacy of mRNA vaccines against coronavirus represented an important support for this type of drug. Now, drug companies plan to use this technology to fight other types of infectious diseases, including the flu. Moderna hopes that mRNA-based flu vaccines will be more effective than traditional ones. Being faster to manufacture, production would not have to start that far in advance and could theoretically be better suited to the typ...
ensayos, Fase I, Noticias, pruebas, Reino Unido, Salud, SIDA, Universidad de Oxford, vacuna, vih

Oxford University Starts HIV Vaccine Trials | Digital Trends Spanish

Researchers at the University of Oxford began phase I trials of a novel vaccine targeting a "wide range" of HIV variants. The HIV-CORE 0052 trial is part of the European AIDS Vaccine Initiative, and will involve 13 healthy, HIV-negative adults between 18 and 65 years of age, who are not considered to be at high risk of infection. Thus, participants will receive a dose of the vaccine, known as HIVconsvC, followed by another booster dose at four weeks. How does it work? Unlike other vaccine candidates, HIVconsvX is designed to induce immune system T lymphocytes and target highly conserved and vulnerable regions of HIV. “An effective vaccine against HIV has been elusive for 40 years. This trial is the first in a series of evaluations of this novel vaccine strategy both in HIV-negative ind...
coronavirus, Covid 19, janssen, Johnson & Johnson, Noticias, Salud, vacuna, Variante Delta

Janssen vaccine: “strong and resistant” to Delta variant | Digital Trends Spanish

Pharmaceutical Johnson & Johnson, parent of the Belgian company Janssen, has indicated that its vaccine against COVID-19 is effective and safe against the Delta variant. According to the laboratory, it offers an immune response that lasts for at least eight months, although it has not indicated data on the percentages of efficacy. “The studies strengthen the ability of Johnson & Johnson's COVID-19 vaccine to help protect the health of people around the world. We believe our vaccine offers long-lasting protection and neutralizing activity against the Delta variant, ”said Johnson & Johnson Chief Scientific Officer Paul Stoffels. “The data corresponding to the eight months studied so far show that the vaccine generates a strong neutralizing antibody response that does not diminish, but we...
coronavirus, Covid 19, eficacia, Noticias, pandemia, rusia, Salud, Sputnik V, vacuna, variante, Variante Delta

Sputnik V efficiency against delta variant exceeds 90% | Digital Trends Spanish

According to Denis Logunov, deputy director of the Gamaleya Research Center and developer of the Sputnik V vaccine, he assured that the efficacy against the delta variant would be greater than 90 percent. "The efficacy of Sputnik V against the Delta variant is greater than 90 percent, as Sputnik V shows a smaller decrease in the efficacy against Delta than any other vaccine that has published efficacy results in the Delta variant," says the official tweet. of the vaccine quoting the words of Logunov. Dr. Denis Logunov, Sputnik V developer: "Sputnik V efficacy against Delta variant is above 90% as Sputnik V shows smaller decline in efficacy against Delta than any other vaccine that published efficacy results on Delta variant" pic.twitter.com/KunjQo2L0J & mdash; Sputnik V (@sputnikvacci...
Abdala, Covid 19, Cuba, fármacos, Noticias, Salud, SARS-CoV-2, vacuna, vacunas

Abdala: Cuba’s anti-COVID-19 vaccine with 92% efficacy | Digital Trends Spanish

According to BioCubaFarma, the anti-COVID-19 vaccine developed by Cuba would have an efficacy of more than 92.28 percent. According to the laboratory that produced the antigen, it would be close to becoming the first immunizer against the coronavirus created in Latin America. In its social networks, the Island's Center for Genetic Engineering and Biotechnology (CIGB) pointed out that with three doses the patient would obtain more than 90 percent protection against the coronavirus. 💉 Vaccine candidate #Abdala of @CIGBCuba shows an efficacy of 92.28% in its 3-dose scheme, reports @BioCubaFarma. In video, details on how this formulation is produced: https://t.co/RQv79UUgsk pic.twitter.com/zB7LCpSQrk & mdash; Scientific Observatory (@ObservaCiencia) June 22, 2021 Abdala is one of the fiv...
BioNTech, coronavirus, Covid 19, cura, enfermedad, normalidad, Noticias, pacientes, pandemia, regreso a la normalidad, Salud, vacuna, vacunacion, vida normal

When does “normal life” return according to the founder of BioNTech? | Digital Trends Spanish

Pfizer's announcement that its coronavirus vaccine would have been more than 90 percent effective gave us all some hope regarding an eventual (albeit distant) end to the health crisis. Of course, we all have to be aware that the period that follows the application of the vaccine will not be easy, nor will it be perfect. In fact, it will be as hard and difficult as the one we have experienced during this 2020. So at least Ugur Sahin, founder of BioNTech, a German company associated with Pfizer in the development of the vaccine against COVID-19, has announced. In conversation with Sky News, the scientist pointed out that people could start getting vaccinated in the United Kingdom from next month. Of course, this would depend on whether the regulator in that territory approves the dr...
clinicos, Covid 19, efectos asociados, Efectos secundarios, ensayos, inyeccion, laboratorio, Noticias, Pfizer, prueba, Salud, vacuna, vacuna pfizer, vacunacion

What are the side effects of the Pfizer vaccine? | Digital Trends Spanish

More than 43,500 people from six countries have participated in the phase three trials of the pharmaceutical company Pfizer for its coronavirus vaccine. An article from Daily Mail compiles the testimonies of some volunteers who explain what are the main side effects associated with the vaccine. A 45-year-old volunteer noted that the first dose left her with side effects similar to those caused by the flu shot, but that symptoms were more severe after the second dose. Another 44-year-old volunteer claimed that the Pfizer vaccine made him feel like he had a severe hangover, but explained that the symptoms disappeared quickly. A third woman, a publicist from Missouri, said that with the first dose of the vaccine she suffered a headache, fever and discomfort all over her body; however...